Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

China · Delayed Price · Currency is CNY

5.84

+0.10 (1.74%)

Oct 28, 2026, 1:15 PM CST

Market Cap	9.07B -0.1%
Revenue (ttm)	2.03B +7.3%
Net Income	-234.50M
EPS	-0.18
Shares Out	1.55B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,179,214
Open	5.72
Previous Close	5.74
Day's Range	5.44 - 5.84
52-Week Range	4.87 - 9.09
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHE:002099

Zhejiang Hisoar Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in China and internationally. It operates through Pharmaceutical Industry, Dye Industry, and Others segments. The company offers antibiotics, cardiovascular drugs, hypoglycemic agents, formulations, and fine chemicals. It also provides dyes and pigment intermediates; environmental protection-related equipment; medical chemical supplies an... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1966

Employees 2,736

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002099

Full Company Profile

Financial Performance

In 2025, SHE:002099's revenue was 1.86 billion, a decrease of -4.01% compared to the previous year's 1.94 billion. Losses were -91.08 million, -72.42% less than in 2024.

Financial Statements